Antimicrobial Agents Practice Questions

Q: Flu-like symptoms are a side effect of which anti-TB drug?

Rifampicin. ***Rifampicin*** - **Flu-like syndrome** (fever, chills, myalgia, and headache) is a dose-dependent side effect of **rifampicin**, particularly with intermittent dosing. - This reaction is due to **immunological mechanisms**, involving antibodies against rifampicin. *Isoniazid* - The most significant side effect of isoniazid is **hepatotoxicity**, which can range from mild elevated liver enzymes to severe hepatitis. - It can also cause **peripheral neuropathy**, particularly in malnourished patients or those with risk factors, preventable with pyridoxine (vitamin B6) supplementation. *Pyrazinamide* - **Hepatotoxicity** is a major concern with pyrazinamide, often leading to elevated liver enzymes and, in some cases, severe liver damage. - It frequently causes **hyperuricemia**, which can precipitate acute gouty arthritis due to decreased excretion of uric acid. *Ethambutol* - The most characteristic adverse effect of ethambutol is **optic neuritis**, causing decreased visual acuity, red-green color blindness, and visual field defects. - Regular **ophthalmological monitoring** is crucial during treatment to detect this reversible side effect early.

Q: Which of the following is not excreted by the kidney?

Moxifloxacin. ***Moxifloxacin*** - Moxifloxacin is primarily metabolized in the **liver** and excreted through bile and feces. - This characteristic makes it a suitable choice for patients with significant **renal impairment** as dose adjustments are generally not required. *Ciprofloxacin* - Ciprofloxacin is predominantly excreted by the **kidneys** through both glomerular filtration and tubular secretion. - Dose adjustments are crucial in patients with **renal dysfunction** to prevent accumulation and toxicity. *Ofloxacin* - Ofloxacin is largely excreted unchanged in the **urine**, making renal excretion its primary elimination pathway. - **Dose reduction** is necessary for patients with impaired renal function. *Levofloxacin* - Levofloxacin is primarily eliminated via **renal excretion**, with a significant portion appearing in the urine as unmetabolized drug. - Patients with **kidney disease** require appropriate dose adjustments.

Q: Emtricitabine is classified as which of the following?

NRTI. ***NRTI*** - Emtricitabine is a **nucleoside reverse transcriptase inhibitor (NRTI)**, a class of antiretroviral drugs used in the treatment of **HIV infection**. - As an NRTI, it works by inhibiting the enzyme **reverse transcriptase**, which is crucial for the HIV virus to replicate its RNA into DNA. *Alkylating agent* - Alkylating agents are a type of **chemotherapy drug** that kill cancer cells by damaging their DNA. - They are primarily used in **cancer treatment**, not for viral infections like HIV. *Antimetabolite* - Antimetabolites are drugs that interfere with DNA and RNA synthesis, often used in **chemotherapy** to treat cancer or in immunosuppression. - While they can inhibit nucleic acid synthesis, this is a broad category, and emtricitabine's specific mechanism and classification are as an NRTI. *Integrase Inhibitor* - Integrase inhibitors are another class of **antiretroviral drugs** that block the HIV enzyme integrase, preventing the viral DNA from integrating into the host cell's DNA. - While an antiretroviral, emtricitabine has a different mechanism of action and belongs to the NRTI class.

Q: Thymidine is responsible for resistance to which antibiotic ?

Sulfonamide. ***Sulfonamide*** - **Thymidine** can contribute to **sulfonamide resistance** because sulfonamides interfere with **folate metabolism** and the subsequent synthesis of purines and pyrimidines, including thymidine. - An excess of thymidine can bypass the metabolic block caused by sulfonamides, allowing bacteria to continue DNA synthesis and grow. *Erythromycin* - **Erythromycin** resistance is primarily mediated by **methylation of ribosomal RNA**, which prevents the antibiotic from binding to the 50S ribosomal subunit. - It does not directly involve thymidine or the folate synthesis pathway. *Tetracycline* - Resistance to **tetracyclines** is commonly due to **efflux pumps** that actively pump the drug out of the bacterial cell or **ribosomal protection proteins** that prevent tetracycline binding. - Thymidine production or metabolism is not a mechanism of tetracycline resistance. *Nitrofurantoin* - **Nitrofurantoin** resistance typically involves **mutations** in bacterial enzymes (like **nitrofuran reductase**) that are responsible for activating the drug into its active form. - These mutations prevent the drug from becoming bactericidal, and thymidine does not play a role in this mechanism.

Q: Which drug is linked to hypertrophic pyloric stenosis in infants?

Erythromycin. ***Erythromycin*** - Studies have shown an association between infantile exposure to **erythromycin** and an increased risk of developing **hypertrophic pyloric stenosis**. - This risk is particularly noted when erythromycin is administered during the **first two weeks of life**, possibly due to its potent motilin receptor agonism. *Tetracycline* - **Tetracycline** is known for causing **teeth discoloration** and **bone growth retardation** in infants and children. - It is generally contraindicated in pediatric populations due to these significant side effects, but it is not linked to pyloric stenosis. *Ampicillin* - **Ampicillin** is a penicillin antibiotic commonly used in infants for bacterial infections. - While it can cause side effects like **rashes** and **diarrhea**, there is no established link to hypertrophic pyloric stenosis. *Rifampicin* - **Rifampicin** is an antibiotic primarily used for treating tuberculosis. - Its main side effects include **hepatotoxicity** and **red-orange discoloration of body fluids**, but it has no known association with hypertrophic pyloric stenosis.

Q: Which drug would be most appropriate for treating a patient with suspected chlamydia-gonorrhea coinfection?

Doxycycline. ***Doxycycline*** - **Doxycycline** is a highly effective treatment for **chlamydia**, and its broad-spectrum activity also covers potential **gonorrhea coinfection** when used as part of a dual therapy regimen. - It is often prescribed alongside a **single dose of ceftriaxone** for presumed gonorrhea coinfection, as ceftriaxone targets gonorrhea while doxycycline targets chlamydia. *Ciprofloxacin* - **Ciprofloxacin** is a **fluoroquinolone** antibiotic, which is generally not recommended as first-line treatment for uncomplicated **gonorrhea** or **chlamydia** due to increasing resistance. - It has activity against *Neisseria gonorrhoeae*, but its effectiveness against *Chlamydia trachomatis* is suboptimal compared to macrolides or tetracyclines. *Norfloxacin* - **Norfloxacin** is another **fluoroquinolone** with a narrower spectrum of activity than ciprofloxacin and is primarily used for **urinary tract infections**. - It has **poor efficacy against chlamydia** and is not a recommended treatment for either organism in this context. *Nalidixic acid* - **Nalidixic acid** is a first-generation **quinolone** with a very limited spectrum, used mainly for **gram-negative urinary tract infections**. - It has **no significant activity against chlamydia** or gonorrhea and is therefore inappropriate for treating this suspected coinfection.

Q: What is the treatment for Trichomonas vaginalis?

Metronidazole. ***Metronidazole*** - **Metronidazole** is the **first-line drug** for treating *Trichomonas vaginalis* infection. - It is effective against this **anaerobic protozoan** and can be administered as a single dose or a 7-day course. *Azithromycin* - **Azithromycin** is a **macrolide antibiotic** primarily used to treat bacterial infections, such as **chlamydia** or certain **respiratory tract infections**. - It is **not effective** against *Trichomonas vaginalis*, which is a parasitic protozoan. *Ciprofloxacin* - **Ciprofloxacin** is a **fluoroquinolone antibiotic** used for bacterial infections, especially **urinary tract infections** and complicated **gastrointestinal infections**. - It has **no activity** against *Trichomonas vaginalis*. *None of the options* - This option is incorrect because **Metronidazole** is a highly effective and widely accepted treatment for *Trichomonas vaginalis* infections.

Q: What is the recommended single dose treatment for gonorrhea?

Ceftriaxone. ***Ceftriaxone*** - **Ceftriaxone** is the **recommended first-line single dose treatment** for uncomplicated gonorrhea, given as a **500 mg intramuscular injection**. - As per current guidelines (CDC 2020+), **ceftriaxone monotherapy** is preferred due to its high efficacy and the discontinuation of routine dual therapy. - Ceftriaxone, a third-generation cephalosporin, maintains excellent activity against *Neisseria gonorrhoeae* with minimal resistance reported. *Azithromycin* - **Azithromycin alone** is **not recommended** as single-dose monotherapy for gonorrhea due to increasing macrolide resistance and treatment failures. - While previously used in dual therapy with ceftriaxone, routine dual therapy was discontinued in 2020 guidelines. - Azithromycin remains the first-line treatment for **chlamydia** (1 g single dose), which often co-occurs with gonorrhea and should be treated separately if detected. *Tetracycline* - **Tetracycline** is **not effective** against current strains of *Neisseria gonorrhoeae* due to widespread resistance. - Tetracyclines are primarily used for bacterial infections like **chlamydia** (doxycycline 100 mg twice daily for 7 days), **acne**, and **rickettsial infections**. *Erythromycin* - **Erythromycin** is **not a recommended treatment** for gonorrhea due to high rates of resistance and poor efficacy. - It is used for conditions like **streptococcal pharyngitis** in penicillin-allergic patients and some **atypical pneumonias**.

Q: What is the drug of choice for the treatment of kala-azar?

Liposomal Amphotericin B. ***Liposomal Amphotericin B*** - It is currently considered the **drug of choice** for treating **visceral leishmaniasis (kala-azar)** due to its high efficacy and better tolerability profile compared to conventional amphotericin B. - The **liposomal formulation** allows for targeted delivery to macrophages, where *Leishmania* parasites reside, reducing systemic toxicity. *Amphotericin B* - While effective against *Leishmania*, conventional **Amphotericin B deoxycholate** is associated with significant **nephrotoxicity** and other severe side effects. - It is generally reserved for cases where liposomal amphotericin B is unavailable or as an alternative in specific clinical situations. *Quinine* - **Quinine** is an **antimalarial drug** primarily used for the treatment of *Plasmodium falciparum* malaria. - It has no significant efficacy against *Leishmania* species, which are the causative agents of kala-azar. *Paromomycin* - **Paromomycin** is an **aminoglycoside antibiotic** that can be used as an alternative treatment for visceral leishmaniasis, especially in combination therapies. - Although effective, it is generally not considered the first-line **drug of choice** globally, and its efficacy can vary by region.

Q: What is the mechanism of action of aminoglycoside antibiotics?

Inhibition of protein synthesis. ***Inhibition of protein synthesis*** - Aminoglycosides **bind irreversibly to the 30S ribosomal subunit** of bacteria, interfering with the initiation complex formation and causing misreading of mRNA. - This leads to the production of **non-functional proteins** and ultimately bacterial cell death, making them bactericidal. *Disruption of the cell membrane* - This mechanism is characteristic of **polymyxins** (e.g., colistin), which interact with bacterial cell membranes, increasing permeability and causing leakage of intracellular contents. - Aminoglycosides do not primarily target the cell membrane for their bactericidal action. *Inhibition of DNA replication* - This mechanism is associated with **fluoroquinolones**, which inhibit bacterial topoisomerase II (DNA gyrase) and topoisomerase IV. - Aminoglycosides do not interfere with DNA synthesis or replication. *Inhibition of bacterial cell wall synthesis* - This is the mechanism of action for **beta-lactam antibiotics** (e.g., penicillins, cephalosporins) and **glycopeptides** (e.g., vancomycin), which target peptidoglycan synthesis. - Aminoglycosides do not affect the bacterial cell wall but rather their intracellular protein machinery.

Question 1

Flu-like symptoms are a side effect of which anti-TB drug?

Accepted Answer

Rifampicin

Answer

Isoniazid

Answer

Pyrazinamide

Answer

Ethambutol

Question 2

Which of the following is not excreted by the kidney?

Accepted Answer

Moxifloxacin

Answer

Ciprofloxacin

Answer

Ofloxacin

Answer

Levofloxacin

Question 3

Emtricitabine is classified as which of the following?

Accepted Answer

NRTI

Answer

Alkylating agent

Answer

Antimetabolite

Answer

Integrase Inhibitor

Question 4

Thymidine is responsible for resistance to which antibiotic ?

Accepted Answer

Sulfonamide

Answer

Erythromycin

Answer

Tetracycline

Answer

Nitrofurantoin

Question 5

Which drug is linked to hypertrophic pyloric stenosis in infants?

Accepted Answer

Erythromycin

Answer

Ampicillin

Answer

Rifampicin

Answer

Tetracycline

Question 6

Which drug would be most appropriate for treating a patient with suspected chlamydia-gonorrhea coinfection?

Accepted Answer

Doxycycline

Answer

Ciprofloxacin

Answer

Nalidixic acid

Answer

Norfloxacin

Question 7

What is the treatment for Trichomonas vaginalis?

Accepted Answer

Metronidazole

Answer

Azithromycin

Answer

Ciprofloxacin

Answer

None of the options

Question 8

What is the recommended single dose treatment for gonorrhea?

Accepted Answer

Ceftriaxone

Answer

Erythromycin

Answer

Tetracycline

Answer

Azithromycin

Question 9

What is the drug of choice for the treatment of kala-azar?

Accepted Answer

Liposomal Amphotericin B

Answer

Amphotericin B

Answer

Quinine

Answer

Paromomycin

Question 10

What is the mechanism of action of aminoglycoside antibiotics?

Accepted Answer

Inhibition of protein synthesis

Answer

Inhibition of DNA replication

Answer

Disruption of the cell membrane

Answer

Inhibition of bacterial cell wall synthesis

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?